Clinical Trials List
Protocol NumberM25-288
Not yet recruiting
2026-04-01 - 2031-10-31
Phase II/III
Recruiting3
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- 王秀慈 無
- Che-Hung Lin 無
- Chi-Ching Chen 無
- Chang-Fang Chiu 無
- 陳珈妤 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Ping Hung 無
- Shao-Jung Hsu 無
- Hung-Yuan Yu 無
- 陳明晃 無
- Pei-Chang Lee 無
- 唐振育 無
- 邱乃祈 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hui-Ching Wang 無
- Yung-Yeh Su 無
- Tsung-Jang Yeh 無
- 梁博程 無
- Jeng-Shiun Du 無
- 謝子禹 無
- 王閔宏 無
- Shih-Chang Chuang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
900 participants
